Whiteside, David J. http://orcid.org/0000-0002-5890-9220
Holland, Negin
Tsvetanov, Kamen A.
Mak, Elijah
Malpetti, Maura http://orcid.org/0000-0001-8923-9656
Savulich, George http://orcid.org/0000-0002-6513-5454
Jones, P. Simon http://orcid.org/0000-0001-9695-0702
Naessens, Michelle
Rouse, Matthew A.
Fryer, Tim D.
Hong, Young T.
Aigbirhio, Franklin I.
Mulroy, Eoin
Bhatia, Kailash P.
Rittman, Timothy http://orcid.org/0000-0003-1063-6937
O’Brien, John T. http://orcid.org/0000-0002-0837-5080
Rowe, James B. http://orcid.org/0000-0001-7216-8679
Article History
Received: 4 April 2023
Accepted: 7 December 2023
First Online: 20 December 2023
Competing interests
: The authors declare the following competing interests: James B Rowe is a non-remunerated trustee of the Guarantors of Brain. He provides consultancy to Asceneuron, Astronautx, Astex, Biogen, Curasen, CumulusNeuro, Prevail, SVHealth and Wave, and has research grants from AZ-Medimmune, Janssen, Lilly and GSK as industry partners in the Dementias Platform UK. John T O’Brien has acted as a consultant for TauRx, Novo Nordisk, Biogen, Roche, Lilly and GE Healthcare and received grant or academic support from Avid/ Lilly, Merck, UCB and Alliance Medical. All other authors declare no competing interests.